Ketogenic Diet and Breast Cancer: Recent Findings and Therapeutic Approaches

• Published in: Nutrients 2023-10, Vol.15 (20), p.4357
• Main Authors: Urzì, Alfio Giuseppe, Tropea, Emanuela, Gattuso, Giuseppe, Spoto, Graziana, Marsala, Gabriella, Calina, Daniela, Libra, Massimo, Falzone, Luca
• Format: Article
• Language: English
• Subjects: Alcohol; Breast cancer; Cancer therapies; Carcinogens; Chemotherapy; Circadian rhythm; Development and progression; Diet; Drug therapy; Endocrine therapy; Epidemiology; Epidermal growth factor; Estrogens; Evidence-based medicine; glycemic load; Health aspects; Hormones; integrated treatments; ketogenesis; ketogenic diet; Meat; Medical prognosis; Medical research; Medicine, Experimental; Metabolism; Metabolites; Pertuzumab; proteins; Review; Risk factors; Type 2 diabetes
• ISSN: 2072-6643; 2072-6643
• DOI: 10.3390/nu15204357

Breast cancer (BC), a complex disease with several influencing factors, is significantly impacted by dietary habits. The ketogenic diet (KD), characterized by high fat and low carbohydrate intake, has gained attention as a potential therapeutic approach, but its effects on BC remain unclear. This review seeks to summarize the current knowledge on the principles of the KD, its metabolic influence on BC cells, and the findings of recent clinical trials, in order to elucidate the potential therapeutic role of the KD in BC management. For these purposes, a comprehensive literature review was conducted selecting preclinical and clinical studies that investigate the relationship between the KD and BC. The selection criteria prioritized studies exploring the KD’s metabolic effects on BC cells and current clinical trials involving the KD in BC management. The reviewed studies provide a diverse range of findings, with some suggesting potential benefits of the KD in inhibiting tumor growth and improving treatment response. However, robust clinical trials providing clear evidence of the KD’s efficacy as a standalone therapeutic approach in BC are still lacking. There are also significant concerns regarding the safety and long-term effects of sustained ketosis in cancer patients. The therapeutic potential of the KD in BC remains an area of active research and debate. While preliminary findings are promising, definitive conclusions are hindered by inconsistent results and limited human trial data. Future research, specifically well-structured, large-scale clinical trials, is necessary to provide a comprehensive understanding of the role of the KD in BC treatment. Until then, caution should be exercised in its application, and patients should continue prioritizing evidence-based, standard-of-care treatments.